Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_assertion type Assertion NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_head.
- NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_assertion description "[Next, using the NK-92 (mCD16) we compared mouse mAbs directed at B lineage specific CD antigens for their ability to induce ADCC against human Epstein-Barr virus- infected B lymphoblastoid (for anti-CD19, -CD20 and -CD21) or against myeloma (for anti-CD38 and -CD138) target cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_provenance.
- NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_assertion evidence source_evidence_literature NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_provenance.
- NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_assertion SIO_000772 23770975 NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_provenance.
- NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_assertion wasDerivedFrom befree-20150227 NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_provenance.
- NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_assertion wasGeneratedBy ECO_0000203 NP911232.RAz9xZ1ZIwWO2Ypks9Jx_U3kQiiaGaMnCjAIcVPHTHTew130_provenance.